Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Same-Day Discharge After Transcatheter Aortic Valve Implantation: Who, When, and How?

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Incidence, Clinical Characteristics and Outcomes of Severe Prosthesis-Patient Mismatch in Patients Undergoing TAVI with Large Aortic Annuli.

Medicina (Kaunas, Lithuania)·2026
Same author

Corrigendum to "Influence of simulation on the knowledge, skills, and confidence of entry-to-practice nursing students to recognise and respond to occupational violence and aggression: A scoping review". [Nurse Educ. Today 158 (2026) 106939].

Nurse education today·2026
Same author

Navigating the Hidden Curriculum: A Study of Resource-Based and Stories-Based Interventions in Higher Education.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Correction: Unlocking interstitial fluid for acute coronary syndrome diagnosis: ultrasensitive troponin I detection using imprinted polymer nanoparticles.

Nanoscale horizons·2026
Same author

Differences in cardiac output of patients undergoing trans-catheter aortic valve implantation according to their underlying rhythm.

World journal of cardiology·2026

Related Experiment Video

Updated: Feb 2, 2026

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

455

ORBITA: What Goes Around, Comes Around… Or Does It?

Matthew Jackson1, Azfar Zaman1

  • 1Freeman Hospital, High Heaton Newcastle-Upon-Tyne, UK.

Interventional Cardiology (London, England)
|November 17, 2018
PubMed
Summary

Percutaneous coronary intervention (PCI) did not improve exercise time for stable angina patients on optimal medical therapy (OMT). The ORBITA trial suggests PCI may not be superior to placebo for symptom relief in select CAD patients.

Keywords:
ORBITAStable anginacoronary artery diseasefraction-flow reservepercutaneous coronary interventionplacebo controlled

More Related Videos

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
08:42

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures

Published on: May 26, 2023

4.1K
Isolation, Propagation, and Prion Protein Expression During Neuronal Differentiation of Human Dental Pulp Stem Cells
11:50

Isolation, Propagation, and Prion Protein Expression During Neuronal Differentiation of Human Dental Pulp Stem Cells

Published on: March 18, 2019

7.8K

Related Experiment Videos

Last Updated: Feb 2, 2026

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

455
Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
08:42

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures

Published on: May 26, 2023

4.1K
Isolation, Propagation, and Prion Protein Expression During Neuronal Differentiation of Human Dental Pulp Stem Cells
11:50

Isolation, Propagation, and Prion Protein Expression During Neuronal Differentiation of Human Dental Pulp Stem Cells

Published on: March 18, 2019

7.8K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Current guidelines suggest percutaneous coronary intervention (PCI) for stable angina despite optimal medical therapy (OMT).
  • Previous trials have not demonstrated a reduction in death or myocardial infarction with PCI.
  • The ORBITA trial investigated the efficacy of PCI in patients with stable angina and single-vessel coronary artery disease (CAD).

Purpose of the Study:

  • To compare the effectiveness of OMT plus PCI versus OMT plus a 'placebo' PCI in patients with stable angina and CAD.
  • To assess the impact of PCI on exercise capacity in patients with ongoing symptoms despite OMT.

Main Methods:

  • The ORBITA trial randomized patients with stable angina and single-vessel CAD to either OMT + PCI or OMT + 'placebo' PCI.
  • Exercise treadmill testing was used to measure the primary endpoint of change in exercise time after six weeks.
  • Patients were carefully selected, and invasive physiological testing was performed.

Main Results:

  • No significant difference in treadmill exercise time was observed between the OMT + PCI group and the OMT + 'placebo' PCI group.
  • The trial demonstrated the feasibility of placebo-controlled trials for invasive cardiac procedures.
  • Despite the methodology, the results were interpreted by some as questioning the role of PCI in stable angina management.

Conclusions:

  • While methodologically significant, the ORBITA trial's highly selected population and specific patient characteristics limit its generalizability.
  • The trial does not negate the potential benefit of ischaemia-guided revascularisation for patients whose symptoms persist despite optimal medical therapy.
  • Further research is needed to clarify the role of PCI in managing stable angina symptoms refractory to medical treatment.